Addrenex Pharmaceuticals.
DURHAM -- Addrenex Pharmaceuticals reached a development deal
potentially worth more than $200 million with Atlanta-based Sciele
Pharma. Addrenex is working on treatments for hypertension and hot
flashes caused by menopause.
COPYRIGHT 2008 Business North
Carolina Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.
Browse by Journal Name: